Developing impurities analytical methods with a quality by design approachAccurate, QC-Tested SPE Cartridges for the Analysis of PFAS in Environmental SamplesAmino Acid AnalysisXII International Exhibition LabComplEX- 2019Choosing the Best UPLC System for Your Application Needs: Autosampler Designs in LCsEnhance your sample prep and chromatography for environmental contaminant analysisJoin us for a series of FREE webinars on “Mass Spectrometry Fundamentals”Join us for the most interactive biopharma event of the year!Waters New RenataDX Screening System Delivers Fast, Accurate Results for Clinical ScientistsThe Historical Role of Mass Spectrometry in Newborn Screening

Developing impurities analytical methods with a quality by design approach

1
The presence of impurities, even at trace levels, may affect the quality, safety and efficacy of drug products. Impurities in a drug substance or drug product can arise from chemical synthesis, degradation, manufacturing, storage conditions, packaging, excipients or contamination. Analytical method development for impurity detection and quantitation is a necessary and often challenging task for…
Read more...

Accurate, QC-Tested SPE Cartridges for the Analysis of PFAS in Environmental Samples

Picture1
Introducing Waters Oasis WAX for PFAS Analysis. Designed for environmental testing laboratories that need to perform low level LC-MS quantification of per- and polyfluoroalkyl substances (PFAS) in environmental samples, the Oasis WAX for PFAS Analysis enables PFAS extraction and concentration without the risk of cross contamination through a comprehensive quality control pre-screening test for 32…
Read more...

Amino Acid Analysis

Determination and control of critical nutrients in cell culture is important to maximize protein yield and provide a consistent manufacturing process. The Waters UPLC®Amino Acid Analysis (AAA) Solution is a turnkey solution that provides accurate, high throughput amino acid analysis. The UPLC Amino Acid Analysis Solution meets the specific demands of analyzing amino acids for…
Read more...

XII International Exhibition LabComplEX- 2019

25-27 September was one of the most important events in the laboratory industry in Ukraine, covering a wide range of laboratory equipment, supplies, cutting-edge technologies, special selection of furniture for your laboratory and interesting reports from specialists in the field of research and medicine. Our company has been participating in this event since 2018 and,…
Read more...

Enhance your sample prep and chromatography for environmental contaminant analysis

September 25, 2019 at 16:00 BST / 11:00 EDT / 08:00 PDT / 17:00 CEST This webinar will highlight sample preparation and chromatography considerations during both routine and advanced LC-MS/MS workflows, for trace level contaminants including PFAS and GenX compounds. While per- and polyfluorinated alkyl substances (PFAS) continue to persist throughout the environment, additional interest…
Read more...

Join us for the most interactive biopharma event of the year!

Join us for the most interactive biopharma event of the year! 15th-17th October Royal Marine Hotel, Dublin Language: English The Waters European Biopharma Analytical Forum provides a unique opportunity to meet other biopharma experts across Europe, discuss your challenges and share your experience. It is an interactive and collaborative event but also an occasion to discover the latest innovations in…
Read more...

Waters New RenataDX Screening System Delivers Fast, Accurate Results for Clinical Scientists

In Vitro Diagnostic Device Designed for Dried Blood Spot Analysis Waters New RenataDX Screening System Delivers Fast, Accurate Results for Clinical Scientists October 10, 2018 08:00 AM Eastern Daylight Time MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) introduced the RenataDX™ Screening System, a flow-injection tandem mass spectrometry (FIA-MS/MS) system for rapid high-throughput analysis of extracted dried blood spots…
Read more...

The Historical Role of Mass Spectrometry in Newborn Screening

3
From the Guthrie Test to a unique technology collaboration Newborn screening for inherited metabolic disorders dates to the early 1960s, when Dr. Robert Guthrie in Buffalo, New York developed the first screening test for phenylketonuria (or PKU), a metabolic disease in which patients can’t metabolize the amino acid phenylalanine. The so-called “Guthrie Test” was simple,…
Read more...